Targeted Degradation of 53BP1 Using Ubiquitin Variant Induced Proximity

In recent years, researchers have leveraged the ubiquitin-proteasome system (UPS) to induce selective degradation of proteins by E3 ubiquitin ligases, which has great potential as novel therapeutics for human diseases, including cancer and neurodegenerative disorders. However, despite extensive effo...

Full description

Bibliographic Details
Main Authors: Bayonle Aminu, Julia Fux, Evan Mallette, Nathaniel Petersen, Wei Zhang
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/12/4/479
_version_ 1797436733114023936
author Bayonle Aminu
Julia Fux
Evan Mallette
Nathaniel Petersen
Wei Zhang
author_facet Bayonle Aminu
Julia Fux
Evan Mallette
Nathaniel Petersen
Wei Zhang
author_sort Bayonle Aminu
collection DOAJ
description In recent years, researchers have leveraged the ubiquitin-proteasome system (UPS) to induce selective degradation of proteins by E3 ubiquitin ligases, which has great potential as novel therapeutics for human diseases, including cancer and neurodegenerative disorders. However, despite extensive efforts, only a handful of ~600 human E3 ligases were utilized, and numerous protein–protein interaction surfaces on E3 ligases were not explored. To tackle these problems, we leveraged a structure-based protein engineering technology to develop a multi-domain fusion protein bringing functional E3 ligases to the proximity of a target protein to trigger its proteasomal degradation, which we termed Ubiquitin Variant Induced Proximity (UbVIP). We first generated non-inhibitory synthetic UbV binders for a selected group of human E3 ligases. With these UbVs employed as E3 ligase engagers, we designed a library of UbVIPs targeting a DNA damage response protein 53BP1. We observed that two UbVIPs recruiting RFWD3 and NEDD4L could effectively induce proteasome degradation of 53BP1 in human cell lines. This provides a proof-of-principle that UbVs can act as a means of targeted degradation for nucleus-localized proteins. Our work demonstrated that UbV technology is suitable to develop protein-based molecules for targeted degradation and can help identify novel E3 ligases for future therapeutic development.
first_indexed 2024-03-09T11:06:48Z
format Article
id doaj.art-23f11e7cfc334a04892f52598fcca073
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-03-09T11:06:48Z
publishDate 2022-03-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-23f11e7cfc334a04892f52598fcca0732023-12-01T00:55:07ZengMDPI AGBiomolecules2218-273X2022-03-0112447910.3390/biom12040479Targeted Degradation of 53BP1 Using Ubiquitin Variant Induced ProximityBayonle Aminu0Julia Fux1Evan Mallette2Nathaniel Petersen3Wei Zhang4Department of Molecular and Cellular Biology, College of Biological Science, University of Guelph, 50 Stone Rd E, Guelph, ON N1G 2W1, CanadaDepartment of Molecular and Cellular Biology, College of Biological Science, University of Guelph, 50 Stone Rd E, Guelph, ON N1G 2W1, CanadaDepartment of Molecular and Cellular Biology, College of Biological Science, University of Guelph, 50 Stone Rd E, Guelph, ON N1G 2W1, CanadaDepartment of Molecular and Cellular Biology, College of Biological Science, University of Guelph, 50 Stone Rd E, Guelph, ON N1G 2W1, CanadaDepartment of Molecular and Cellular Biology, College of Biological Science, University of Guelph, 50 Stone Rd E, Guelph, ON N1G 2W1, CanadaIn recent years, researchers have leveraged the ubiquitin-proteasome system (UPS) to induce selective degradation of proteins by E3 ubiquitin ligases, which has great potential as novel therapeutics for human diseases, including cancer and neurodegenerative disorders. However, despite extensive efforts, only a handful of ~600 human E3 ligases were utilized, and numerous protein–protein interaction surfaces on E3 ligases were not explored. To tackle these problems, we leveraged a structure-based protein engineering technology to develop a multi-domain fusion protein bringing functional E3 ligases to the proximity of a target protein to trigger its proteasomal degradation, which we termed Ubiquitin Variant Induced Proximity (UbVIP). We first generated non-inhibitory synthetic UbV binders for a selected group of human E3 ligases. With these UbVs employed as E3 ligase engagers, we designed a library of UbVIPs targeting a DNA damage response protein 53BP1. We observed that two UbVIPs recruiting RFWD3 and NEDD4L could effectively induce proteasome degradation of 53BP1 in human cell lines. This provides a proof-of-principle that UbVs can act as a means of targeted degradation for nucleus-localized proteins. Our work demonstrated that UbV technology is suitable to develop protein-based molecules for targeted degradation and can help identify novel E3 ligases for future therapeutic development.https://www.mdpi.com/2218-273X/12/4/479Ubiquitin Varianttargeted protein degradationPROTACE3 ligase53BP1NEDD4L
spellingShingle Bayonle Aminu
Julia Fux
Evan Mallette
Nathaniel Petersen
Wei Zhang
Targeted Degradation of 53BP1 Using Ubiquitin Variant Induced Proximity
Biomolecules
Ubiquitin Variant
targeted protein degradation
PROTAC
E3 ligase
53BP1
NEDD4L
title Targeted Degradation of 53BP1 Using Ubiquitin Variant Induced Proximity
title_full Targeted Degradation of 53BP1 Using Ubiquitin Variant Induced Proximity
title_fullStr Targeted Degradation of 53BP1 Using Ubiquitin Variant Induced Proximity
title_full_unstemmed Targeted Degradation of 53BP1 Using Ubiquitin Variant Induced Proximity
title_short Targeted Degradation of 53BP1 Using Ubiquitin Variant Induced Proximity
title_sort targeted degradation of 53bp1 using ubiquitin variant induced proximity
topic Ubiquitin Variant
targeted protein degradation
PROTAC
E3 ligase
53BP1
NEDD4L
url https://www.mdpi.com/2218-273X/12/4/479
work_keys_str_mv AT bayonleaminu targeteddegradationof53bp1usingubiquitinvariantinducedproximity
AT juliafux targeteddegradationof53bp1usingubiquitinvariantinducedproximity
AT evanmallette targeteddegradationof53bp1usingubiquitinvariantinducedproximity
AT nathanielpetersen targeteddegradationof53bp1usingubiquitinvariantinducedproximity
AT weizhang targeteddegradationof53bp1usingubiquitinvariantinducedproximity